In vitro uptake of dopamine in serotoninergic nerve terminals: a fluorescence histochemical study on vibratome sections of the rat cerebral cortex
- PMID: 358786
In vitro uptake of dopamine in serotoninergic nerve terminals: a fluorescence histochemical study on vibratome sections of the rat cerebral cortex
Similar articles
-
On the visualization of central dopamine and noradrenaline nerve terminals in cryostat sections.Med Biol. 1976 Aug;54(4):278-85. Med Biol. 1976. PMID: 957814
-
Dopamine uptake in serotoninergic terminals in vitro: a valuable tool for the histochemical differentiation of catecholaminergic and serotoninergic terminals in rat cerebral structures.Brain Res. 1978 May 19;147(1):29-45. doi: 10.1016/0006-8993(78)90770-9. Brain Res. 1978. PMID: 350350
-
Noradrenaline and dopamine interaction in rat brain during development.Med Biol. 1981 Jun;59(3):161-9. Med Biol. 1981. PMID: 6796787
-
Putative neurotransmitters in the brain: selective neuronal uptake, subcellular localization, and interactions with centrally acting drugs.Biol Psychiatry. 1970 Oct;2(4):367-89. Biol Psychiatry. 1970. PMID: 4320227 Review. No abstract available.
-
[Recent acquisitions on cerebral metabolism of catecholamines].Actual Pharmacol (Paris). 1967;20:29-68. Actual Pharmacol (Paris). 1967. PMID: 4894123 Review. French. No abstract available.
Cited by
-
Striatal serotonin transporter gain-of-function in L-DOPA-treated, hemi-parkinsonian rats.Brain Res. 2023 Jul 15;1811:148381. doi: 10.1016/j.brainres.2023.148381. Epub 2023 Apr 29. Brain Res. 2023. PMID: 37127174 Free PMC article.
-
Characterization of 3,4-methylenedioxymethamphetamine (MDMA) enantiomers in vitro and in the MPTP-lesioned primate: R-MDMA reduces severity of dyskinesia, whereas S-MDMA extends duration of ON-time.J Neurosci. 2011 May 11;31(19):7190-8. doi: 10.1523/JNEUROSCI.1171-11.2011. J Neurosci. 2011. PMID: 21562283 Free PMC article.
-
The serotonergic system in motor and non-motor manifestations of Parkinson's disease.Exp Brain Res. 2013 Oct;230(4):463-76. doi: 10.1007/s00221-013-3621-2. Epub 2013 Jun 28. Exp Brain Res. 2013. PMID: 23811734 Review.
-
Monoamine reuptake inhibitors in Parkinson's disease.Parkinsons Dis. 2015;2015:609428. doi: 10.1155/2015/609428. Epub 2015 Feb 25. Parkinsons Dis. 2015. PMID: 25810948 Free PMC article. Review.
-
The monoamine re-uptake inhibitor UWA-101 improves motor fluctuations in the MPTP-lesioned common marmoset.PLoS One. 2012;7(9):e45587. doi: 10.1371/journal.pone.0045587. Epub 2012 Sep 20. PLoS One. 2012. PMID: 23029119 Free PMC article.